30 Years of Evidence
Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.
Featured Content
sarcoma awareness
Neoadjuvant Image-guided Helical Intensity Modulated Radiotherapy of Extremity Sarcomas - A Single Center Experience
sarcoma awareness
Effectiveness and Safety of Tissue Expander for Adjuvant Helical TomoTherapy in Curatively Resected Retroperitoneal Sarcoma
sarcoma awareness
Treatment of Chordomas and Chondrosarcomas With CyberKnife Robotic Hypofractionated Radiosurgery: A Single Institution Experience
Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy | ESTRO | 2026
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
María Pagola | ESTRO | 2026
Dosimetric evaluation of real-time adaptive radiotherapy with Radixact® Synchrony® for lung carcinoma
Gaetano Gagliardo, Italy | ESTRO | 2026
Online adaptive radiotherapy using integrated vendor platforms: workflow timings using Radixact® and Raystation.
Samira Shire, United Kingdom | ESTRO | 2026
Development and implementation of online adaptive radiotherapy (oART) using a Radixact delivery platform in combination with the RayStation TPS
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
Stereotactic radiotherapy for non-spine bone metastases: a mono-institutional experience
Francesco Cuccia | ESTRO | 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Single-fraction SBRT with Radixact for lung malignancies: early outcomes of a single-center experience
Francesco Cuccia, Italy | ESTRO | 2026
Early post-SBRT CT patterns and dosimetric factors predict recurrence in solitary lung nodules
María Pagola | ESTRO | 2026
Dosimetric evaluation of real-time adaptive radiotherapy with Radixact® Synchrony® for lung carcinoma
Gaetano Gagliardo, Italy | ESTRO | 2026
Online adaptive radiotherapy using integrated vendor platforms: workflow timings using Radixact® and Raystation.
Samira Shire, United Kingdom | ESTRO | 2026
Development and implementation of online adaptive radiotherapy (oART) using a Radixact delivery platform in combination with the RayStation TPS
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
Stereotactic radiotherapy for non-spine bone metastases: a mono-institutional experience
Francesco Cuccia | ESTRO | 2026
Interested in conducting research with the CyberKnife® or Radixact® / TomoTherapy® Systems?
If you’re a member of Accuray Exchange (AEx), you can complete a collaboration application form here.
